Rite Aid's troubles continue to mount.
The struggling drug store chain disclosed that it is no longer in compliance with New York Stock Exchange (NYSE) continued listing standards, which require a $1.00 average closing share price over a 30 trading-day period. (As of Thursday late afternoon, Rite Aid’s stock was trading at about $0.54 on the NYSE.)
Under NYSE rules, Rite Aid will be provided with “cure periods” and the company’s common stock will continue to be listed and traded on the NYSE during these periods, subject to its compliance with other continued listing requirements.
Rite Aid may file bankruptcy, close stores
This NYSE non-compliance notice comes on the heels of media reports that Rite Aid is preparing a Chapter 11 bankruptcy plan which involves store liquidations, according to a report by The Wall Street Journal. Under the plan, Rite Aid would close 400 to 500 of its more than 2,100 stores and either sell or let creditors take over its remaining operations, the report said.
In August, the Journal reported that Rite Aid was preparing to file for bankruptcy protection in a move to deal with its more than $3.3 billion in long-term debt and lawsuits related to opioid prescriptions. The expected Chapter 11 filing would cover Rite Aid’s debt load and pending legal allegations that it oversupplied prescription painkillers.
The current noncompliance with NYSE listing standards does not affect Rite Aid’s ongoing business operations or U.S. Securities and Exchange Commission reporting requirements, nor does it trigger any violation of its material debt or other obligations. However, Rite Aid says it can provide no assurances that it will be able to regain compliance with the NYSE’s continued listing standards or maintain the listing of its shares on the NYSE.